Pharma executives say big data, radio frequency identification, automation and other innovations used in supply-chain tracking and tracing will be the most important digital innovation for their companies in the next five years, according to a recent Bain & Company survey. The group ranked predictive analytics second in importance for its ability to increase diagnostic accuracy and speed. Third was real-time data and remote monitoring, which will enable new markers of success or failure in clinical trials, reduce required visits to a physician and lower the cost of clinical trials.
Jason Evers is a partner in Bain & Company’s Healthcare practice. He is based in Bain’s Chicago office.
Bain Insights dig deep into the complex challenges that healthcare companies—including hospitals, insurers and medtech firms—face in patient care.